Skip to main content

ADVERTISEMENT

Shirling Tsai, MD

Original Contribution
01/09/2015
We analyzed data from the ongoing multicenter XLPAD registry to report on the use of non-stent (atherectomy ± balloon angioplasty) and stent-based treatment of superficial femoral ar-tery (SFA), popliteal, and below-the-knee (BTK) vessels in...
We analyzed data from the ongoing multicenter XLPAD registry to report on the use of non-stent (atherectomy ± balloon angioplasty) and stent-based treatment of superficial femoral ar-tery (SFA), popliteal, and below-the-knee (BTK) vessels in...
We analyzed data from the...
01/09/2015
Journal of Invasive Cardiology
Original Contribution
09/30/2018
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically...
09/30/2018
Journal of Invasive Cardiology
Original Contribution
11/30/2022
Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.
Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.
Few studies have directly...
11/30/2022
Journal of Invasive Cardiology